LPI (LP Information)' newest research report, the “AI Drug Discovery Industry Forecast” looks at past sales and reviews total world AI Drug Discovery sales in 2022, providing a comprehensive analysis by region and market sector of projected AI Drug Discovery sales for 2023 through 2029. With AI Drug Discovery sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Drug Discovery industry.
This Insight Report provides a comprehensive analysis of the global AI Drug Discovery landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI Drug Discovery portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Drug Discovery market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Drug Discovery and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Drug Discovery.
The global AI Drug Discovery market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for AI Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI Drug Discovery is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI Drug Discovery players cover Microsoft Corporation, NVIDIA Corporation, IBM Corporation, Google, Atomwise, Inc., Deep Genomics, Cloud Pharmaceuticals, Inc., Insilico Medicine and Benevolentai, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of AI Drug Discovery market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Software
Services
Segmentation by application
Immuno-Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Microsoft Corporation
NVIDIA Corporation
IBM Corporation
Google
Atomwise, Inc.
Deep Genomics
Cloud Pharmaceuticals, Inc.
Insilico Medicine
Benevolentai
Exscientia
Cyclica
Bioage
Numerate
Envisagenics
TwoXAR
Owkin, Inc.
Xtalpi, Inc.
Verge Genomics
Berg LLC

1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global AI Drug Discovery Market Size 2018-2029 2.1.2 AI Drug Discovery Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 AI Drug Discovery Segment by Type 2.2.1 Software 2.2.2 Services 2.3 AI Drug Discovery Market Size by Type 2.3.1 AI Drug Discovery Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global AI Drug Discovery Market Size Market Share by Type (2018-2023) 2.4 AI Drug Discovery Segment by Application 2.4.1 Immuno-Oncology 2.4.2 Neurodegenerative Diseases 2.4.3 Cardiovascular Disease 2.4.4 Metabolic Diseases 2.4.5 Others 2.5 AI Drug Discovery Market Size by Application 2.5.1 AI Drug Discovery Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global AI Drug Discovery Market Size Market Share by Application (2018-2023) 3 AI Drug Discovery Market Size by Player 3.1 AI Drug Discovery Market Size Market Share by Players 3.1.1 Global AI Drug Discovery Revenue by Players (2018-2023) 3.1.2 Global AI Drug Discovery Revenue Market Share by Players (2018-2023) 3.2 Global AI Drug Discovery Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 AI Drug Discovery by Regions 4.1 AI Drug Discovery Market Size by Regions (2018-2023) 4.2 Americas AI Drug Discovery Market Size Growth (2018-2023) 4.3 APAC AI Drug Discovery Market Size Growth (2018-2023) 4.4 Europe AI Drug Discovery Market Size Growth (2018-2023) 4.5 Middle East & Africa AI Drug Discovery Market Size Growth (2018-2023) 5 Americas 5.1 Americas AI Drug Discovery Market Size by Country (2018-2023) 5.2 Americas AI Drug Discovery Market Size by Type (2018-2023) 5.3 Americas AI Drug Discovery Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC AI Drug Discovery Market Size by Region (2018-2023) 6.2 APAC AI Drug Discovery Market Size by Type (2018-2023) 6.3 APAC AI Drug Discovery Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe AI Drug Discovery by Country (2018-2023) 7.2 Europe AI Drug Discovery Market Size by Type (2018-2023) 7.3 Europe AI Drug Discovery Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa AI Drug Discovery by Region (2018-2023) 8.2 Middle East & Africa AI Drug Discovery Market Size by Type (2018-2023) 8.3 Middle East & Africa AI Drug Discovery Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global AI Drug Discovery Market Forecast 10.1 Global AI Drug Discovery Forecast by Regions (2024-2029) 10.1.1 Global AI Drug Discovery Forecast by Regions (2024-2029) 10.1.2 Americas AI Drug Discovery Forecast 10.1.3 APAC AI Drug Discovery Forecast 10.1.4 Europe AI Drug Discovery Forecast 10.1.5 Middle East & Africa AI Drug Discovery Forecast 10.2 Americas AI Drug Discovery Forecast by Country (2024-2029) 10.2.1 United States AI Drug Discovery Market Forecast 10.2.2 Canada AI Drug Discovery Market Forecast 10.2.3 Mexico AI Drug Discovery Market Forecast 10.2.4 Brazil AI Drug Discovery Market Forecast 10.3 APAC AI Drug Discovery Forecast by Region (2024-2029) 10.3.1 China AI Drug Discovery Market Forecast 10.3.2 Japan AI Drug Discovery Market Forecast 10.3.3 Korea AI Drug Discovery Market Forecast 10.3.4 Southeast Asia AI Drug Discovery Market Forecast 10.3.5 India AI Drug Discovery Market Forecast 10.3.6 Australia AI Drug Discovery Market Forecast 10.4 Europe AI Drug Discovery Forecast by Country (2024-2029) 10.4.1 Germany AI Drug Discovery Market Forecast 10.4.2 France AI Drug Discovery Market Forecast 10.4.3 UK AI Drug Discovery Market Forecast 10.4.4 Italy AI Drug Discovery Market Forecast 10.4.5 Russia AI Drug Discovery Market Forecast 10.5 Middle East & Africa AI Drug Discovery Forecast by Region (2024-2029) 10.5.1 Egypt AI Drug Discovery Market Forecast 10.5.2 South Africa AI Drug Discovery Market Forecast 10.5.3 Israel AI Drug Discovery Market Forecast 10.5.4 Turkey AI Drug Discovery Market Forecast 10.5.5 GCC Countries AI Drug Discovery Market Forecast 10.6 Global AI Drug Discovery Forecast by Type (2024-2029) 10.7 Global AI Drug Discovery Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Microsoft Corporation 11.1.1 Microsoft Corporation Company Information 11.1.2 Microsoft Corporation AI Drug Discovery Product Offered 11.1.3 Microsoft Corporation AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Microsoft Corporation Main Business Overview 11.1.5 Microsoft Corporation Latest Developments 11.2 NVIDIA Corporation 11.2.1 NVIDIA Corporation Company Information 11.2.2 NVIDIA Corporation AI Drug Discovery Product Offered 11.2.3 NVIDIA Corporation AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 NVIDIA Corporation Main Business Overview 11.2.5 NVIDIA Corporation Latest Developments 11.3 IBM Corporation 11.3.1 IBM Corporation Company Information 11.3.2 IBM Corporation AI Drug Discovery Product Offered 11.3.3 IBM Corporation AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 IBM Corporation Main Business Overview 11.3.5 IBM Corporation Latest Developments 11.4 Google 11.4.1 Google Company Information 11.4.2 Google AI Drug Discovery Product Offered 11.4.3 Google AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 Google Main Business Overview 11.4.5 Google Latest Developments 11.5 Atomwise, Inc. 11.5.1 Atomwise, Inc. Company Information 11.5.2 Atomwise, Inc. AI Drug Discovery Product Offered 11.5.3 Atomwise, Inc. AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Atomwise, Inc. Main Business Overview 11.5.5 Atomwise, Inc. Latest Developments 11.6 Deep Genomics 11.6.1 Deep Genomics Company Information 11.6.2 Deep Genomics AI Drug Discovery Product Offered 11.6.3 Deep Genomics AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Deep Genomics Main Business Overview 11.6.5 Deep Genomics Latest Developments 11.7 Cloud Pharmaceuticals, Inc. 11.7.1 Cloud Pharmaceuticals, Inc. Company Information 11.7.2 Cloud Pharmaceuticals, Inc. AI Drug Discovery Product Offered 11.7.3 Cloud Pharmaceuticals, Inc. AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Cloud Pharmaceuticals, Inc. Main Business Overview 11.7.5 Cloud Pharmaceuticals, Inc. Latest Developments 11.8 Insilico Medicine 11.8.1 Insilico Medicine Company Information 11.8.2 Insilico Medicine AI Drug Discovery Product Offered 11.8.3 Insilico Medicine AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Insilico Medicine Main Business Overview 11.8.5 Insilico Medicine Latest Developments 11.9 Benevolentai 11.9.1 Benevolentai Company Information 11.9.2 Benevolentai AI Drug Discovery Product Offered 11.9.3 Benevolentai AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Benevolentai Main Business Overview 11.9.5 Benevolentai Latest Developments 11.10 Exscientia 11.10.1 Exscientia Company Information 11.10.2 Exscientia AI Drug Discovery Product Offered 11.10.3 Exscientia AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Exscientia Main Business Overview 11.10.5 Exscientia Latest Developments 11.11 Cyclica 11.11.1 Cyclica Company Information 11.11.2 Cyclica AI Drug Discovery Product Offered 11.11.3 Cyclica AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Cyclica Main Business Overview 11.11.5 Cyclica Latest Developments 11.12 Bioage 11.12.1 Bioage Company Information 11.12.2 Bioage AI Drug Discovery Product Offered 11.12.3 Bioage AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Bioage Main Business Overview 11.12.5 Bioage Latest Developments 11.13 Numerate 11.13.1 Numerate Company Information 11.13.2 Numerate AI Drug Discovery Product Offered 11.13.3 Numerate AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Numerate Main Business Overview 11.13.5 Numerate Latest Developments 11.14 Envisagenics 11.14.1 Envisagenics Company Information 11.14.2 Envisagenics AI Drug Discovery Product Offered 11.14.3 Envisagenics AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 Envisagenics Main Business Overview 11.14.5 Envisagenics Latest Developments 11.15 TwoXAR 11.15.1 TwoXAR Company Information 11.15.2 TwoXAR AI Drug Discovery Product Offered 11.15.3 TwoXAR AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 TwoXAR Main Business Overview 11.15.5 TwoXAR Latest Developments 11.16 Owkin, Inc. 11.16.1 Owkin, Inc. Company Information 11.16.2 Owkin, Inc. AI Drug Discovery Product Offered 11.16.3 Owkin, Inc. AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.16.4 Owkin, Inc. Main Business Overview 11.16.5 Owkin, Inc. Latest Developments 11.17 Xtalpi, Inc. 11.17.1 Xtalpi, Inc. Company Information 11.17.2 Xtalpi, Inc. AI Drug Discovery Product Offered 11.17.3 Xtalpi, Inc. AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.17.4 Xtalpi, Inc. Main Business Overview 11.17.5 Xtalpi, Inc. Latest Developments 11.18 Verge Genomics 11.18.1 Verge Genomics Company Information 11.18.2 Verge Genomics AI Drug Discovery Product Offered 11.18.3 Verge Genomics AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.18.4 Verge Genomics Main Business Overview 11.18.5 Verge Genomics Latest Developments 11.19 Berg LLC 11.19.1 Berg LLC Company Information 11.19.2 Berg LLC AI Drug Discovery Product Offered 11.19.3 Berg LLC AI Drug Discovery Revenue, Gross Margin and Market Share (2018-2023) 11.19.4 Berg LLC Main Business Overview 11.19.5 Berg LLC Latest Developments 12 Research Findings and Conclusion